1. Home
  2. GPUS vs TOVX Comparison

GPUS vs TOVX Comparison

Compare GPUS & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPUS
  • TOVX
  • Stock Information
  • Founded
  • GPUS 1969
  • TOVX 2001
  • Country
  • GPUS United States
  • TOVX United States
  • Employees
  • GPUS N/A
  • TOVX N/A
  • Industry
  • GPUS
  • TOVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GPUS
  • TOVX Health Care
  • Exchange
  • GPUS NYSE
  • TOVX Nasdaq
  • Market Cap
  • GPUS 4.1M
  • TOVX 4.7M
  • IPO Year
  • GPUS 1996
  • TOVX 2006
  • Fundamental
  • Price
  • GPUS $2.75
  • TOVX $1.35
  • Analyst Decision
  • GPUS
  • TOVX Strong Buy
  • Analyst Count
  • GPUS 0
  • TOVX 1
  • Target Price
  • GPUS N/A
  • TOVX $6.00
  • AVG Volume (30 Days)
  • GPUS 107.5K
  • TOVX 49.4K
  • Earning Date
  • GPUS 04-15-2025
  • TOVX 05-06-2025
  • Dividend Yield
  • GPUS N/A
  • TOVX N/A
  • EPS Growth
  • GPUS N/A
  • TOVX N/A
  • EPS
  • GPUS N/A
  • TOVX N/A
  • Revenue
  • GPUS $139,425,000.00
  • TOVX N/A
  • Revenue This Year
  • GPUS N/A
  • TOVX N/A
  • Revenue Next Year
  • GPUS N/A
  • TOVX N/A
  • P/E Ratio
  • GPUS N/A
  • TOVX N/A
  • Revenue Growth
  • GPUS 3.50
  • TOVX N/A
  • 52 Week Low
  • GPUS $2.62
  • TOVX $1.14
  • 52 Week High
  • GPUS $20.30
  • TOVX $17.00
  • Technical
  • Relative Strength Index (RSI)
  • GPUS N/A
  • TOVX 44.64
  • Support Level
  • GPUS N/A
  • TOVX $1.28
  • Resistance Level
  • GPUS N/A
  • TOVX $1.60
  • Average True Range (ATR)
  • GPUS 0.00
  • TOVX 0.11
  • MACD
  • GPUS 0.00
  • TOVX -0.02
  • Stochastic Oscillator
  • GPUS 0.00
  • TOVX 14.94

About GPUS HYPERSCALE DATA INC

Hyperscale Data Inc, formerly Ault Alliance Inc is a diversified holding company. It operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, crane services, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles. The company has eight reportable segments: Energy and Infrastructure; Technology and Finance; SMC; Sentinum, Inc.; GIGA; TurnOnGreen; ROI; and Ault Disruptive.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Share on Social Networks: